BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9365158)

  • 1. Hypermethylation of the WT1 and calcitonin gene promoter regions at chromosome 11p in human colorectal cancer.
    Hiltunen MO; Koistinaho J; Alhonen L; Myöhänen S; Marin S; Kosma VM; Pääkkönen M; Jänne J
    Br J Cancer; 1997; 76(9):1124-30. PubMed ID: 9365158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.
    Loeb DM; Evron E; Patel CB; Sharma PM; Niranjan B; Buluwela L; Weitzman SA; Korz D; Sukumar S
    Cancer Res; 2001 Feb; 61(3):921-5. PubMed ID: 11221883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma.
    Hiltunen MO; Alhonen L; Koistinaho J; Myöhänen S; Pääkkönen M; Marin S; Kosma VM; Jänne J
    Int J Cancer; 1997 Mar; 70(6):644-8. PubMed ID: 9096643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
    Cowell JK; Groves N; Baird P
    Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
    Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
    World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas.
    Laux DE; Curran EM; Welshons WV; Lubahn DB; Huang TH
    Breast Cancer Res Treat; 1999 Jul; 56(1):35-43. PubMed ID: 10517341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of calcitonin gene regulatory sequences in human breast cancer as revealed by genomic sequencing.
    Hakkarainen M; Wahlfors J; Myöhänen S; Hiltunen MO; Eskelinen M; Johansson R; Jänne J
    Int J Cancer; 1996 Dec; 69(6):471-4. PubMed ID: 8980249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of WTAP, a novel Wilms' tumour 1-associating protein.
    Little NA; Hastie ND; Davies RC
    Hum Mol Genet; 2000 Sep; 9(15):2231-9. PubMed ID: 11001926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X; Xing G; Saunders GF
    Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
    McCoy C; McGee SB; Cornwell MM
    Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging and DNA methylation in colorectal mucosa and cancer.
    Ahuja N; Li Q; Mohan AL; Baylin SB; Issa JP
    Cancer Res; 1998 Dec; 58(23):5489-94. PubMed ID: 9850084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
    Roberts DJ; Haber D; Sklar J; Crum CP
    Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human breast and colon cancers exhibit alterations of DNA methylation patterns at several DNA segments on chromosomes 11p and 17p.
    Ribieras S; Song-Wang XG; Martin V; Lointier P; Frappart L; Dante R
    J Cell Biochem; 1994 Sep; 56(1):86-96. PubMed ID: 7806594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlapping DNA recognition motifs between Sp1 and a novel trans-acting factor within the wt1 tumour suppressor gene promoter.
    Discenza MT; Dehbi M; Pelletier J
    Nucleic Acids Res; 1997 Nov; 25(21):4314-22. PubMed ID: 9336463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. +P5 (D1S3309E), a novel target binding site for the Wilms' tumour suppressor 1 (WT1) gene, maps to human chromosome 1q21-->22.
    Negus K; Holmes GH; Wicking C; Wainwright BJ; Little MH
    Cytogenet Cell Genet; 1996; 72(4):306-9. PubMed ID: 8641136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Wilms' tumor suppressor gene (wt1) product represses different functional classes of transcriptional activation domains.
    Lee TH; Moffett P; Pelletier J
    Nucleic Acids Res; 1999 Jul; 27(14):2889-97. PubMed ID: 10390530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a tumor-specific methylation site in the Wilms tumor suppressor gene.
    Kleymenova EV; Yuan X; LaBate ME; Walker CL
    Oncogene; 1998 Feb; 16(6):713-20. PubMed ID: 9488035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK; Brown KW; Berry PJ
    Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
    Moelans CB; Verschuur-Maes AH; van Diest PJ
    J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours.
    Ramani P; Cowell JK
    J Pathol; 1996 Jun; 179(2):162-8. PubMed ID: 8758208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.